The Conference Board analysts say the question isn’t why China will slow, but why anyone thinks it won’t
Tablets remain a problem in a record-breaking quarter
From Michael Dunn's trial in Florida to discord over open-carry laws in Colorado, the debate about gun control has driven Americans to indulge their worst behavior
The company misses earnings forecasts, drops its 2015 profit goal, and regroups
Chinese millionaires are moving in—and building up—in Arcadia, Calif.
A new book surveys the best places to hide out from the digital world
The two tech giants fight over market share and patents but not over the NBA superstar
Professor Piotr Naskrecki blogged about finding and killing one of the largest type of spider in the world, triggering a barrage of hate mail
Small businesses are changing hands at the fastest pace since the recession
Founder: Dr. John Hadden
VC Investment over the last four quarters: $25 million
IRX Therapeutics is a 40-employee biotech firm developing drugs to restore immune system function, particularly in patients with head and neck cancer. Founded over a decade ago and backed by more than $60 million raised mostly from high-net-worth individuals, the company has reduced headcount by a third and delayed some clinical trials planned for 2009, according to Chief Financial Officer Jeffrey Hwang.
Key to startup success: "In normal times where the capital is available, the difference maker among people with good ideas is sharp execution. There's never a substitute for the ability to attract and retain experienced, qualified people to take advantage of the discovery you've made."